DLast reviewed
Rapamycin and mTOR: the strongest mouse lifespan data
Robust, replicated mouse lifespan extension; human evidence is limited to immune and safety studies. Prescription drug, not a supplement.

Editorial section. Research summaries are not product claims and contain no product links or offers. A summary is never proof that any product works.
- The question
- Does rapamycin extend lifespan, and what is known in people?
- Study design
- NIA Interventions Testing Program at three sites (2009); a randomized trial of an mTOR inhibitor and vaccine response in older adults (2014). [1][2][3]
- What they found
- Rapamycin started at the mouse equivalent of about 60 human years extended median and maximum lifespan in both sexes. In older adults, a short course of an mTOR inhibitor improved flu vaccine response. [1][2][3]
- Limitations
- No human lifespan data. Side effects and dosing for healthy people are unresolved.
- What this does not mean
- This is context for the field, not a recommendation. Rapamycin requires a prescriber.
- Sources
- Harrison DE et al. Nature. 2009;460:392-395. doi.org/10.1038/nature08221
- Mannick JB et al. Sci Transl Med. 2014;6(268):268ra179. doi.org/10.1126/scitranslmed.3009892
- Miller RA et al. J Gerontol A. 2011;66(2):191-201. doi.org/10.1093/gerona/glq178
Where it is discussed on podcasts
Verified episodes. Hosts and guests do not endorse Everstack. Podcast index
- Huberman Lab: Dr. Peter Attia: Supplements for Longevity & Their Efficacy (2024-07-29)
- The Peter Attia Drive: #175 Matt Kaeberlein, Ph.D.: The biology of aging, rapamycin, and other interventions that target the aging process (2021-09-13)
Spot an error? Email hello@everstackhealth.com and we will correct it within 48 hours.